Naratriptan Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Naratriptan Bisaryl Naratriptan VE009124View CAS 1346604-16-7
Naratriptan N-Sulfamoylethyl Naratriptan VE009125View CAS 1346746-73-3
Naratriptan N-Sulfamoylethyl Naratriptan Pyridinium VE009126View CAS 2144776-33-8
Naratriptan N-methyl-2-(1-(3-methylpiperidin-4-yl)-1H-indol-5-yl)-N-(2-(methylsulfonyl)ethyl)ethane-1-sulfonamide VE009128View
Naratriptan Naratriptan Inhouse Impurity B VE008860View CAS 121679-20-7
Naratriptan Naratriptan Pyridinium VE009127View
Naratriptan 3-(1-Methyl-4-piperidinyl)-1H-indole VE008862View CAS 17403-07-5
Naratriptan 4-Pyridinemethanol VE0010147View CAS 586-95-8
Naratriptan 5-Ethyl-3-(1-methylpiperidin-4-yl)-1H-indole VE008861View CAS 2074613-76-4

Request a quote

121679-20-7: Naratriptan Inhouse Impurity B

121679-20-7: Naratriptan Inhouse Impurity B
Catalogue No.

VE008860
CAS No.

121679-20-7
Molecular Formula

C17H23N3O2S
Molecular Weight

333.45 g/mol
Parent drug

Naratriptan
IUPAC Name

N-Methyl-3-(1, 2, 3, 6-tetrahydro-1-methyl-4-pyridinyl)-1H-indole-5-ethanesulfonamide
Synonyms

3, 4-Dihydro Naratriptan
References

Ong, Jonathan Jia Yuan, and Milena De Felice. “Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.” Neurotherapeutics, vol. 15, no. 2, Dec. 2017, pp. 274–90, https://doi.org/10.1007/s13311-017-0592-1. ‌
Status

In-stock
ListName

Naratriptan Inhouse Impurity B
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url